By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    What Are the Benefits of CBD?
    November 27, 2021
    How to Measure Adult Diapers- The Ultimate Guide to Picking the Right Size
    March 8, 2022
    medicine cabinet
    The Effect Of Finished Dosage Form Manufacturing In New Drugs
    July 5, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Medical Negligence
    The Impact of Medical Negligence: How Claims Can Help You Move Forward
    January 6, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
    PPACA: “It’s in there!”
    September 9, 2017
    Latest News
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
    Top HIPAA-Compliant Messaging Apps for Healthcare Teams
    June 25, 2025
    When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
    June 20, 2025
    Preventing Contamination In Healthcare Facilities Starts With Hygiene
    June 15, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Inovio Wins Award for Cervical Cancer Vaccine Research
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Inovio Wins Award for Cervical Cancer Vaccine Research
Technology

Inovio Wins Award for Cervical Cancer Vaccine Research

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

Inovio Pharmaceuticals (AMEX:INO) announced Wednesday that it has won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer, at the recent fifth Vaccine and ISV Global Congress.

Inovio Pharmaceuticals (AMEX:INO) announced Wednesday that it has won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer, at the recent fifth Vaccine and ISV Global Congress.

Inovio’s poster, entitled “Induction of HPV specific CTLs in human volunteers after DNA immunization,” was selected from over 500 abstracts by the scientific organizing committee and an expert panel of judges, the company said.

The award citation highlighted Inovio’s therapeutic cervical dysplasia and cancer vaccine program, as well as the assay for determining vaccine impact.

More Read

GAO: FDA Can’t Monitor Device Recalls
New Technologies at Medtech Startups, June 2011
How Technology Will Improve the Future for Rare Diseases
Gene Therapy Is Back And Is Working for Some Patients
Can Big Data Analytics Make Telemedicine More Functional?

The Vaccine Congress is a report on the latest progress in the development of vaccines for infectious and non-infectious diseases. The annual Jenner Award is named after Edward Jenner (1749-1823), who is widely credited as the pioneer of the smallpox vaccine and is often referred to as the “Father of Immunology.”

Inovio presented data showing the development of a new assay used to test cytolytic T cell activity in immunized patients. Blood samples collected from subjects immunized with Inovio’s SynCon  therapeutic HPV vaccine (VGX-3100) were analyzed by the new assay.

The company previously announced the results of its phase one clinical trial of the vaccine, demonstrating strong T-cell immune responses. But the important aspect of the vaccine is its ability to generate antigen-specific cytolytic T cells that can kill infected host cells.

Using the new assay, Inovio scientists were able to demonstrate for the first time that the vaccines developed fully functional cytolytic T cells capable of killing targets in an antigen-specific manner — a finding that may prove crucial to the success of an effective therapy for HPV-related disease.

More than 30 to 40 types of the HPV virus are typically transmitted through sexual contact and cause genital warts. Persistent infection with “high-risk” HPV types may progress to precancerous lesions and cancer.

Inovio president and CEO, Dr. J. Joseph Kim, said: “We greatly appreciate this recognition of Inovio’s leadership and innovation in advancing the development of novel vaccines and analytical methods to assess vaccine effects.

“Our SynCon  vaccines administered with our proprietary electroporation delivery systems have generated best-in-class immune responses in our Phase I clinical trials for cervical dysplasia and HIV.

“The demonstration of antigen-specific CTL activity induced by Inovio’s synthetic vaccines delivered by its proprietary CELLECTRA  electroporation system speaks well for our synthetic vaccine platform in general and in particular for our cancer vaccine programs.”

Inovio has active therapeutic vaccine programs for HPV types associated with cervical dysplasia/cancer, chronic myeloid leukemia , prostate cancer, hepatitis C virus and HIV.– Deborah Sterescu

 

TAGGED:cancer
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

car accident lawsuit
Let Your Lawyer Handle the Work Before You Pay Medical Costs
Policy & Law
July 6, 2025
women dental care
What Is a Smile Makeover and How Much Does It Cost?
Dental health
June 30, 2025
HIPAA-Compliant Messaging Apps
Top HIPAA-Compliant Messaging Apps for Healthcare Teams
Global Healthcare Policy & Law Technology
June 25, 2025
recovering from injury
Rebuilding After Injury: Path to Physical and Emotional Recovery
News
June 22, 2025

You Might also Like

sealants-global-market
Medical DevicesMedical InnovationsSpecialtiesTechnology

Advanced Wound Closure’s New Players

February 28, 2013
health IT
BusinessTechnology

Will a New Market for Better Doctors Arise in 2015?

January 26, 2015

Assuring Safe Patient Health Information (PHI) in Radiology

August 14, 2014
Medical InnovationsTechnology

How Medical Prototyping Is Revolutionizing The Way Medicine Is Practiced

August 5, 2020
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?